Bonus BioGroup Ltd. (BONS.TA)
ILA 9.1
(0.0%)
ILA 9.1
(0.0%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | -29.79 Million ILS | 19.59% |
| 2022 | -37.04 Million ILS | 42.77% |
| 2021 | -64.73 Million ILS | -232.93% |
| 2020 | -19.44 Million ILS | 7.01% |
| 2019 | -20.9 Million ILS | -13.33% |
| 2018 | -18.45 Million ILS | 8.35% |
| 2017 | -20.13 Million ILS | -26.1% |
| 2016 | -15.96 Million ILS | -19.14% |
| 2015 | -13.39 Million ILS | -19.84% |
| 2014 | -11.18 Million ILS | -15.53% |
| 2013 | -9.67 Million ILS | 46.13% |
| 2012 | -17.96 Million ILS | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q2 | -7.21 Million ILS | 12.4% |
| 2024 Q1 | -8.23 Million ILS | -20.58% |
| 2023 Q4 | -6.82 Million ILS | 8.91% |
| 2023 Q3 | -7.49 Million ILS | -2.94% |
| 2023 FY | -29.79 Million ILS | 19.59% |
| 2023 Q1 | -8.18 Million ILS | 17.64% |
| 2023 Q2 | -7.28 Million ILS | 11.07% |
| 2022 Q3 | -8.26 Million ILS | 10.69% |
| 2022 Q2 | -9.25 Million ILS | 3.34% |
| 2022 FY | -37.04 Million ILS | 42.77% |
| 2022 Q1 | -9.57 Million ILS | -0.08% |
| 2022 Q4 | -9.94 Million ILS | -20.21% |
| 2021 Q1 | -36.76 Million ILS | -520.04% |
| 2021 Q3 | -10.37 Million ILS | -29.25% |
| 2021 Q4 | -9.57 Million ILS | 7.75% |
| 2021 FY | -64.73 Million ILS | -232.93% |
| 2021 Q2 | -8.02 Million ILS | 78.16% |
| 2020 Q2 | -4.15 Million ILS | 17.74% |
| 2020 FY | -19.44 Million ILS | 7.01% |
| 2020 Q4 | -5.92 Million ILS | -37.6% |
| 2020 Q3 | -4.3 Million ILS | -3.71% |
| 2020 Q1 | -5.05 Million ILS | -10.36% |
| 2019 Q1 | -7.55 Million ILS | -49.43% |
| 2019 Q2 | -4.21 Million ILS | 44.2% |
| 2019 Q3 | -4.56 Million ILS | -8.18% |
| 2019 Q4 | -4.57 Million ILS | -0.35% |
| 2019 FY | -20.9 Million ILS | -13.33% |
| 2018 Q4 | -5.05 Million ILS | -14.7% |
| 2018 Q3 | -4.4 Million ILS | -11.37% |
| 2018 Q2 | -3.95 Million ILS | 21.28% |
| 2018 Q1 | -5.02 Million ILS | -36.63% |
| 2018 FY | -18.45 Million ILS | 8.35% |
| 2017 Q2 | -3.58 Million ILS | -2.02% |
| 2017 Q1 | -3.51 Million ILS | -6.81% |
| 2017 Q3 | -9.35 Million ILS | -160.84% |
| 2017 FY | -20.13 Million ILS | -26.1% |
| 2017 Q4 | -3.68 Million ILS | 60.65% |
| 2016 Q3 | -6.31 Million ILS | -98.21% |
| 2016 Q4 | -3.29 Million ILS | 47.87% |
| 2016 Q1 | -3.17 Million ILS | 27.69% |
| 2016 Q2 | -3.18 Million ILS | -0.19% |
| 2016 FY | -15.96 Million ILS | -19.14% |
| 2015 FY | -13.39 Million ILS | -19.84% |
| 2015 Q2 | -2.92 Million ILS | -12.59% |
| 2015 Q1 | -2.59 Million ILS | 9.89% |
| 2015 Q4 | -4.39 Million ILS | -26.22% |
| 2015 Q3 | -3.48 Million ILS | -19.08% |
| 2014 Q1 | -3.19 Million ILS | 2.14% |
| 2014 Q4 | -2.88 Million ILS | -32.99% |
| 2014 Q3 | -2.16 Million ILS | 26.72% |
| 2014 Q2 | -2.95 Million ILS | 7.42% |
| 2014 FY | -11.18 Million ILS | -15.53% |
| 2013 FY | -9.67 Million ILS | 46.13% |
| 2013 Q1 | -2.13 Million ILS | 0.0% |
| 2013 Q4 | -3.26 Million ILS | -31.99% |
| 2013 Q3 | -2.47 Million ILS | -31.4% |
| 2013 Q2 | -1.88 Million ILS | 11.64% |
| 2012 FY | -17.96 Million ILS | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Matricelf Ltd | -12.59 Million ILA | -136.504% |